News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Wednesday, March 18, 2026The European Commission introduces comprehensive reforms including the EU Biotech Act to enhance biopharma competitiveness through extended protections and faster approvals
Oxford Nanopore and A.D.A.M. Innovations Partner to Advance Genomic Medicine in Japan
Wednesday, March 18, 2026Oxford Nanopore Technologies and ADAM Innovations have announced an international collaboration to expand the use of advanced genomic sequencing and support the development of precision medicine in Japan
Roche launches NVIDIA-powered AI factory to advance therapeutics and diagnostics development
Tuesday, March 17, 2026Roche has expanded its global AI infrastructure with the launch of a largescale AI factory powered by advanced computing from NVIDIA The system includes highperformance GPUs deployed across the United States
UBriGene Supports FDA IND Clearance for GT307 TIL Therapy
Tuesday, March 17, 2026UBriGene Biosciences a global CDMO has supported its strategic partner Grit Biotechnologies in securing clearance from the US Food and Drug Administration FDA for an Investigational New Drug IND
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Monday, March 16, 2026The European Commissions Health Package introduces the EU Biotech Act with SPC extensions and faster approvals to enhance biopharma competitiveness
JPMorgan Identifies Top EU Pharma, Biotech & Life Sciences Stocks Poised for 2026 Growth
Friday, March 13, 2026JPMorgan forecasts significant growth for leading European pharma biotech and life sciences companies in highlighting AstraZeneca Novartis and Bayer among top performers
Aminex Therapeutics receives second FDA orphan drug designation for AMXT 1501 targeting malignant glioma including DIPG
Friday, March 13, 2026Aminex Therapeutics Inc a clinicalstage biotechnology company developing metabolictargeted cancer therapies has received Orphan Drug Designation from the US Food and Drug Administration for AMXT
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Thursday, March 12, 2026The European Commissions Health Package progresses with the EU Biotech Act offering SPC extensions for biotechs and faster clinical trial approvals to enhance life sciences competitiveness
Catalent and GelMEDIX form global partnership to advance iPSC-derived cell therapies for ocular and retinal diseases
Thursday, March 12, 2026GelMEDIX and Catalent have entered a global partnership to support the development and clinical manufacturing of induced pluripotent stem cell iPSCderived therapies aimed at treating ocular and retinal diseases
Curatis and Neupharma Sign Exclusive Licensing Deal to Develop Corticorelin for Brain Oedema Treatment in Japan
Wednesday, March 11, 2026Curatis Holding AG and Neupharma Co Ltd have signed an exclusive licensing and development agreement for corticorelin CPTBE in Japan
